The new data will be discussed by reference to this scenario.
Proton-proton and proton-nucleus data will be used as reference.
The experimental data will be used as reference for designing the new HTS Maglev system.
To off-set the small sample size, wherever possible findings from interview data will be contextualised by reference to general trends or patterns detected by these larger studies.
Quantitative data will be synthesised with reference to Cochrane guidelines for public health interventions.
Key-informant clinician interview data will be coded with reference to the awareness, acceptance, personal use and prescribing patterns, which will be analysed accordingly.
Key-informant policy maker data will be coded with reference to priorities of influenza vaccine preparedness for pandemic outbreaks, and for consideration of policy concerning seasonal influenza.
Participants' data will be anonymised as unique reference codes will be used.
These data will be useful to establish reference range concentrations for these metabolites and for evaluating changes in pyrethroid exposure over time in the United States.
The following data will be extracted: General information: reference identification, the first author of the article, time of publication and the source/journal.
